Zymeworks Inc.
ZYME
$25.10
-$0.93-3.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.61M | 48.73M | 27.11M | 31.03M | 16.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.61M | 48.73M | 27.11M | 31.03M | 16.00M |
| Cost of Revenue | 35.58M | 34.45M | 35.74M | 37.06M | 36.35M |
| Gross Profit | -7.96M | 14.28M | -8.63M | -6.03M | -20.35M |
| SG&A Expenses | 14.15M | 14.95M | 16.99M | 16.19M | 13.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.72M | 49.40M | 52.72M | 53.25M | 50.21M |
| Operating Income | -22.11M | -674.00K | -25.61M | -22.22M | -34.21M |
| Income Before Tax | -18.27M | 2.13M | -22.14M | -17.79M | -29.62M |
| Income Tax Expenses | 1.34M | -186.00K | 496.00K | 5.72M | 226.00K |
| Earnings from Continuing Operations | -19.60M | 2.32M | -22.64M | -23.51M | -29.85M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.60M | 2.32M | -22.64M | -23.51M | -29.85M |
| EBIT | -22.11M | -674.00K | -25.61M | -22.22M | -34.21M |
| EBITDA | -20.56M | 1.82M | -23.02M | -19.22M | -32.19M |
| EPS Basic | -0.26 | 0.03 | -0.30 | -0.31 | -0.39 |
| Normalized Basic EPS | -0.15 | 0.02 | -0.18 | -0.15 | -0.24 |
| EPS Diluted | -0.26 | 0.03 | -0.30 | -0.31 | -0.39 |
| Normalized Diluted EPS | -0.15 | 0.02 | -0.18 | -0.15 | -0.24 |
| Average Basic Shares Outstanding | 75.77M | 75.34M | 75.17M | 74.66M | 76.13M |
| Average Diluted Shares Outstanding | 75.78M | 77.38M | 75.23M | 74.72M | 76.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |